6 November 2026 CHAIR’S ADDRESS TO THE 2026 ANNUAL GENERAL MEETING Dear Shareholders, As I stated at the opening of the meeting, I welcome you to the 2026 Annual General Meeting of CLINUVEL Pharmaceuticals. Whether you are in the room or watching online, thank you for being here. I will begin...
Chair address
Filed with ASX · · 3 pages · English
On 6ix: 6ix.com/news/chair-address-2
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings CallRelease
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL files NEURACTHEL Instant dossier
- Notification of cessation of securities - CUV
- Section 708A Cleansing Statement
- Application for quotation of securities - CUV
- Change in substantial holding
Later from Clinuvel Pharmaceuticals
All Clinuvel Pharmaceuticals news releasesFollow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals